Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk?
about
Low-dose rate brachytherapy for men with localized prostate cancerSecond malignancies after radiotherapy for prostate cancer: systematic review and meta-analysisOxidative DNA damage caused by inflammation may link to stress-induced non-targeted effects.Radiation Induced Bystander Effect in vivo.Genome-wide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11-q14.Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect.High-risk prostate cancer-classification and therapy.A Mouse Ear Model for Bystander Studies Induced by Microbeam Irradiation.Pelvic radiation therapy: Between delight and disaster.The effect of 6 and 15 MV on intensity-modulated radiation therapy prostate cancer treatment: plan evaluation, tumour control probability and normal tissue complication probability analysis, and the theoretical risk of secondary induced malignanciesProstate cancer as a first and second cancer: effect of family history.Bladder cancer in cancer patients: population-based estimates from a large Swedish study.Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.Predictors in the outcome of 125I brachytherapy as monotherapy for prostate cancer.Examining the co-occurrence of bladder and prostate cancer: a worthwhile investigation?Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy.Biochemical relapse-free survival in 400 patients treated with I-125 prostate brachytherapy: the Guildford experience.Survival after prostate brachytherapy in patients aged 60 years and younger.Reducing the toxicity of cancer therapy: recognizing needs, taking action.
P2860
Q24235544-D5386EE2-51AF-4932-9B9C-A21FE9E7476BQ26764960-62B060C4-C891-4867-9EB7-C0C777B7CEE5Q30394633-FF7538A7-1D52-4185-AC21-9645A3D56720Q33992919-1D4BD51A-2366-4803-B9DD-7F644E6ED8F7Q34065183-31475CA0-2C89-4826-B8BC-F6F6D2B55419Q34659767-812C4A9F-82FC-4891-8FF8-7F6AF137A052Q34973673-B2487680-71CE-4CCC-BDF9-AD5BBA331994Q35099489-9735F7AC-06A2-4874-9229-1CE8F4AEB9B1Q35869811-170C1BFA-D9C7-4ED3-80C0-ED71F9729AE5Q35965313-8DF07C59-DDF8-474E-ADA9-C7F8E7A320FFQ36329095-2D5EDC61-8EFB-4238-A547-DD25F8958AF7Q36364402-22AE8AB0-9BA8-4820-880A-43C5BC177FA8Q37345366-99C82D78-98AE-4356-B544-2389EBFC5745Q37400498-69823C94-53EA-4D32-99D3-0198D04EECCBQ37605565-97974BB5-8535-4AFA-9DD0-713622DDFAEBQ37821905-FDAAE31E-5FD1-40FB-81A5-1570FB386268Q40165463-A196A822-C698-4613-A074-254E742DDC99Q41995379-E8CA6C94-19AD-4113-BDDC-C76E6C2015CEQ43576127-09F1826D-2A15-4BBC-A35F-CF247AE188B6Q44279956-964EF201-1F2F-49E8-9448-4CB2802C94E4Q51581622-5E7F8C78-A045-49D4-93F5-E41255FDD2BD
P2860
Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Secondary cancer after radioth ...... we be more aware of the risk?
@en
type
label
Secondary cancer after radioth ...... we be more aware of the risk?
@en
prefLabel
Secondary cancer after radioth ...... we be more aware of the risk?
@en
P1433
P1476
Secondary cancer after radioth ...... we be more aware of the risk?
@en
P2093
Mark S Soloway
Peter J Bostrom
P304
P356
10.1016/J.EURURO.2007.07.002
P407
P577
2007-07-10T00:00:00Z